A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia
Y. Hirayasu, Shinnosuke Sato, Hideaki Takahashi, S. Iida +5 more

